The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Nivolumab With Ipilimumab for Small Cell Lung Cancer

Matthew D. Hellmann, MD
Published Online:7:25 PM, Thu July 6, 2017

Matthew D. Hellmann, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the CheckMate-032 study, which explored nivolumab (Opdivo) with or without ipilimumab (Yervoy) for patients with small cell lung cancer (SCLC).
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.